GSE33290[Accession] - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Search results

Items: 1 to 20 of 57

<< First< Prev

Page of 3

Select item 2000332901.

Gene expression signatures of dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib

(Submitter supplied) Dasatinib has demonstrated efficacy in patients with chronic-phase chronic myeloid leukemia (CML) who had resistance or intolerance to imatinib. However, some patients also develop resistance or intolerance to dasatinib. To identify potential molecular pathways involved in primary resistance to dasatinib in CML, we analyzed gene expression profiles of mononuclear cells of 7 imatinib-resistant patients, collected before and after 1-year dasatinib treatment. more...

Organism:: Homo sapiens

Type:: Expression profiling by array; Non-coding RNA profiling by array

Platforms:: GPL9193 GPL4133
54 Samples

Series

Accession:: GSE33290

ID:: 200033290

PubMed Similar studies Analyze with GEO2R

Select item 1000041332.

Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Feature Number version)

(Submitter supplied) This multi-pack (4X44K) formatted microarray represents a compiled view of the human genome as it is understood today. The sequence information used to design this product was derived from a broad survey of well known sources such as RefSeq, Goldenpath, Ensembl, Unigene and others. The resulting view of the human genome covers 41K unique genes and transcripts which have been verified and optimized by alignment to the human genome assembly and by Agilent's Empirical Validation process. more...

Organism:: Homo sapiens

10 DataSets
838 Series
3 Related Platforms
15421 Samples

Download data: TXT

Platform

Accession:: GPL4133

ID:: 100004133

Select item 1000091933.

IQUSP Human Intron-Exon 44k v2.0

(Submitter supplied) Agilent’s non-contact industrial inkjet printing process uniformly deposits oligo monomers onto specially-prepared glass slides. Custom microarrays are manufactured using Agilent’s non-contact in situ synthesis process of printing 60-mer length oligonucleotide probes, base-by-base, from digital sequence files. This is achieved with an inkjet process which delivers extremely small, accurate volumes (picoliters) of the chemicals to be spotted. more...

Organism:: Homo sapiens

4 Series
49 Samples

Platform

Accession:: GPL9193

ID:: 100009193

Select item 3008224014.

Peripheral blood mononuclear cells of 152-Cy5 pre-treatment and 234-Cy3 post-treatment dasatinib responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-5 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-3 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822401

ID:: 300822401

Select item 3008223245.

Peripheral blood mononuclear cells of 152-Cy3 pre-treatment and 234-Cy5 post-treatment dasatinib responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-3 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-5 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822324

ID:: 300822324

Select item 3008223156.

Peripheral blood mononuclear cells of 150-Cy5 pre-treatment and 240-Cy3 post-treatment dasatinib responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-5 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-3 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822315

ID:: 300822315

Select item 3008222667.

Peripheral blood mononuclear cells of 150-Cy3 pre-treatment and 240-Cy5 post-treatment dasatinib responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-3 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-5 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822266

ID:: 300822266

Select item 3008222418.

Peripheral blood mononuclear cells of 136-Cy5 pre-treatment and 221-Cy3 post-treatment dasatinib responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-5 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-3 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822241

ID:: 300822241

Select item 3008222409.

Peripheral blood mononuclear cells of 136-Cy3 pre-treatment and 221-Cy5 post-treatment dasatinib responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-3 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-5 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822240

ID:: 300822240

Select item 30082223910.

Peripheral blood mononuclear cells of 155-Cy5 pre-treatment and 235-Cy3 post-treatment dasatinib non-responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-5 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-3 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822239

ID:: 300822239

Select item 30082221011.

Peripheral blood mononuclear cells of 155-Cy3 pre-treatment and 235-Cy5 post-treatment dasatinib non-responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-3 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-5 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822210

ID:: 300822210

Select item 30082220012.

Peripheral blood mononuclear cells of 148-Cy5 pre-treatment and 195-Cy3 post-treatment dasatinib non-responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-5 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-3 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822200

ID:: 300822200

Select item 30082213013.

Peripheral blood mononuclear cells of 148-Cy3 pre-treatment and 195-Cy5 post-treatment dasatinib non-responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-3 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-5 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM822130

ID:: 300822130

Select item 30082198614.

Peripheral blood mononuclear cells of 131-Cy5 pre-treatment and 205-Cy3 post-treatment dasatinib non-responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-5 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-3 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM821986

ID:: 300821986

Select item 30082190615.

Peripheral blood mononuclear cells of 131-Cy3 pre-treatment and 205-Cy5 post-treatment dasatinib non-responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-3 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-5 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM821906

ID:: 300821906

Select item 30082187116.

Peripheral blood mononuclear cells of 128-Cy5 pre-treatment and 239-Cy3 post-treatment dasatinib non-responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-5 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-3 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM821871

ID:: 300821871

Select item 30082186117.

Peripheral blood mononuclear cells of 128-Cy3 pre-treatment and 239-Cy5 post-treatment dasatinib non-responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-3 (channel 1) Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-5 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM821861

ID:: 300821861

Select item 30082185418.

Peripheral blood mononuclear cells of 234-Cy5 post-treatment and 152-Cy3 pre-treatment dasatinib responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-5 (channel 1) Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-3 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM821854

ID:: 300821854

Select item 30082159219.

Peripheral blood mononuclear cells of 234-Cy3 post-treatment and 152-Cy5 pre-treatment dasatinib responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-3 (channel 1) Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-5 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM821592

ID:: 300821592

Select item 30082158720.

Peripheral blood mononuclear cells of 240-Cy5 post-treatment and 150-Cy3 pre-treatment dasatinib responder patient

Organism:: Homo sapiens

Source name:: Total RNA from peripheral blood mononuclear cells of post-treatment labeled with Cyanine-5 (channel 1) Total RNA from peripheral blood mononuclear cells of pre-treatment labeled with Cyanine-3 (channel 2)

Platform:: GPL4133
Series:: GSE33224 GSE33290

Sample

Accession:: GSM821587

ID:: 300821587

<< First< Prev

Page of 3

Supplemental Content

Filters: Manage Filters

Find related data

Search details

Important Links

Recent activity

Clear Turn Off Turn On

GSE33290[Accession] (57)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets